Northwest Wealth Management »

BioMarin Pharmaceutical shares owned by Northwest Wealth Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Northwest Wealth Management from 13F filings

Historical chart of Northwest Wealth Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Northwest Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Northwest Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $231k 3.9k 59.43

More positions owned by Northwest Wealth Management

Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Dimensional Etf Trust Short Duration F (DFSD)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr Core Msci Intl (IDEV)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Equity Market (DFUS)
Apple (AAPL)
Dimensional Etf Trust Internatnal Val (DFIV)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Emgmkt (AVEM)

View all positions for Northwest Wealth Management

Top funds holding BioMarin Pharmaceutical

BlackRock
Vanguard Group
Dodge & Cox
PRIMECAP Management Company
Norges Bank Investment Management
State Street Corporation
Viking Global Investors
AQR Capital Management
Geode Capital Management
Dimensional Fund Advisors
Vestal Point Capital
Millennium Management
Capital Research Global Investors
UBS Group
Deep Track Capital

View all funds holding BioMarin Pharmaceutical